Integral Derivatives’s Eastman Chemical EMN Stock Holding History

Integral Derivatives’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,000	Closed	-$1.23M	–	983
2016 Q1	$1.23M	Buy	+17,000	New	+$1.11M	0.04%	321
2015 Q4	–	Sell	-25,700	Closed	-$1.66M	–	1107
2015 Q3	$1.66M	Buy	25,700 +17,700	+221%	+$1.31M	0.05%	357
2015 Q2	$655K	Buy	+8,000	New	+$617K	0.02%	650
2014 Q4	–	Sell	-10,100	Closed	-$817K	–	1415
2014 Q3	$817K	Buy	+10,100	New	+$843K	0.01%	799

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Integral Derivatives's EMN Position: Q4 2015 in Review

Integral Derivatives sold out of Eastman Chemical (EMN) in Q4 2015, closing a stake of 18,977 shares — an estimated $1.23M sold.

Integral Derivatives first reported a position in EMN in Q4 2013 and held it in 6 quarters. The position peaked at $1.6M in Q4 2013. 557 funds tracked by Wall St. Rank hold EMN as of Q4 2015.

Integral Derivatives reported no remaining Eastman Chemical position as of Q4 2015 after selling out during the quarter.
Integral Derivatives sold 18,977 Eastman Chemical shares in Q4 2015, an estimated $1.23M.
Integral Derivatives first reported a position in Eastman Chemical in Q4 2013 and held it in 6 quarters.
Integral Derivatives's Eastman Chemical position peaked at $1.6M in Q4 2013.
557 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2015.

Based on Integral Derivatives's 13F filing for Q4 2015, filed 22 Jan 2016.